Insiders Love These 2 High Growth Stocks

Includes: FDML, GHDX
by: Kapitall

If you like to follow the buying trends of the "smart money," you may also like to follow the buying trends of company insiders. Company insiders, such as members of the board and upper management, report when they buy shares of their company. When they do, this indicates that they are optimistic on their company's outlook and may view the stock as undervalued.

We ran a screen on high-growth stocks, with 5-year projected EPS growth above 20% for those with the most significant net insider buying over the last six months.

Insiders, naturally, work at the companies in question and have more knowledge about the firm than outsiders. When they put their own money on the line to purchase their company's shares it indicates they are bullish about the firm's future, and believe current share price is undervalued.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the two stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.

Do you think these stocks will outperform like insiders expect? Use this list as a starting point for your own analysis.

List sorted by net insider purchases as a percent of share float.

1. Genomic Health Inc. (NASDAQ:GHDX): Focuses on the development and global commercialization of genomic-based clinical laboratory services that analyze the underlying biology of cancer allowing physicians and patients to make individualized treatment decisions. Market cap at $824.1M, most recent closing price at $26.80. Over the last six months, insiders were net buyers of 609,079 shares, which represents about 3.72% of the company's 16.36M share float.

2. Federal-Mogul Corp. (NASDAQ:FDML): Supplies powertrain and safety technologies worldwide. Market cap at $719M, most recent closing price at $7.27. Over the last six months, insiders were net buyers of 332,549 shares, which represents about 1.5% of the company's 22.13M share float.

*Insider data sourced from Yahoo! Finance, all other data sourced from Finviz.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Business relationship disclosure: Business relationship disclosure: Kapitall is a team of analysts. This article was written by Sabina Bhatia, one of our writers. We did not receive compensation for this article (other than from Seeking Alpha), and we have no business relationship with any company whose stock is mentioned in this article.